Dicumarol

Dicumarol

Clinical data
ATC code	B01AA01 (WHO)
Pharmacokinetic data
Protein binding	plasmatic proteins
Metabolism	hepatic
Excretion	faeces, urine
Identifiers
IUPAC name 3,3'-methylenebis(4-hydroxy-2H-chromen-2-one)
CAS Number	66-76-2
PubChem CID	653
DrugBank	APRD00761
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C19H12O6
Molar mass	336.295 g/mol

WikiDoc Resources for Dicumarol
Articles
Most recent articles on Dicumarol Most cited articles on Dicumarol Review articles on Dicumarol Articles on Dicumarol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dicumarol Images of Dicumarol Photos of Dicumarol Podcasts & MP3s on Dicumarol Videos on Dicumarol
Evidence Based Medicine
Cochrane Collaboration on Dicumarol Bandolier on Dicumarol TRIP on Dicumarol
Clinical Trials
Ongoing Trials on Dicumarol at Clinical Trials.gov Trial results on Dicumarol Clinical Trials on Dicumarol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dicumarol NICE Guidance on Dicumarol NHS PRODIGY Guidance FDA on Dicumarol CDC on Dicumarol
Books
Books on Dicumarol
News
Dicumarol in the news Be alerted to news on Dicumarol News trends on Dicumarol
Commentary
Blogs on Dicumarol
Definitions
Definitions of Dicumarol
Patient Resources / Community
Patient resources on Dicumarol Discussion groups on Dicumarol Patient Handouts on Dicumarol Directions to Hospitals Treating Dicumarol Risk calculators and risk factors for Dicumarol
Healthcare Provider Resources
Symptoms of Dicumarol Causes & Risk Factors for Dicumarol Diagnostic studies for Dicumarol Treatment of Dicumarol
Continuing Medical Education (CME)
CME Programs on Dicumarol
International
Dicumarol en Espanol Dicumarol en Francais
Business
Dicumarol in the Marketplace Patents on Dicumarol
Experimental / Informatics
List of terms related to Dicumarol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

For patient information, click here

Dicumarol (or Dicoumarol) is an anticoagulant that functions by as a Vitamin K antagonist (similar to warfarin).

It is a derivative of coumarin.

External links

• Template:DiseasesDB
• Cullen J, Hinkhouse M, Grady M, Gaut A, Liu J, Zhang Y, Weydert C, Domann F, Oberley L (2003). "Dicumarol inhibition of NADPH: quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism". Cancer Res. 63 (17): 5513–20. PMID 14500388.CS1 maint: Multiple names: authors list (link)
• Mironov A, Colanzi A, Polishchuk R, Beznoussenko G, Mironov A, Fusella A, Di Tullio G, Silletta M, Corda D, De Matteis M, Luini A (2004). "Dicumarol, an inhibitor of ADP-ribosylation of CtBP3/BARS, fragments golgi non-compact tubular zones and inhibits intra-golgi transport". Eur J Cell Biol. 83 (6): 263–79. PMID 15511084.CS1 maint: Multiple names: authors list (link)
• Abdelmohsen K, Stuhlmann D, Daubrawa F, Klotz L (2005). "Dicumarol is a potent reversible inhibitor of gap junctional intercellular communication". Arch Biochem Biophys. 434 (2): 241–7. PMID 15639223.CS1 maint: Multiple names: authors list (link)
• Thanos C, Liu Z, Reineke J, Edwards E, Mathiowitz E (2003). "Improving relative bioavailability of dicumarol by reducing particle size and adding the adhesive poly(fumaric-co-sebacic) anhydride". Pharm Res. 20 (7): 1093–100. PMID 12880296.CS1 maint: Multiple names: authors list (link)

Template:WikiDoc Sources